Articles | Volume 5, issue 1
https://doi.org/10.7150/jbji.40333
© Author(s) 2020. This work is distributed under
the Creative Commons Attribution 4.0 License.Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France
Cited articles
Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 20 mai. 1998;279(19):1537–41.
Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. avr. 2014;27(2):302–45. [PMC free article]
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM. et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. janv. 2013;56(1):e1–25.